Vivo Capital Surplus Fund VIII, L.P., 10% Owner at Bolt Biotherapeutics, Inc. (BOLT), sold 77,843 shares at $0.92 ($72K) on 2023-11-20, disclosed to the SEC on 2023-11-20.
Open-market sale of $72k BOLT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.96 | 1,040 | $998 | 1.4% |
| 2 | $0.96 | 6,429 | $6K | 8.5% |
| 3 | $0.96 | 7,531 | $7K | 10.0% |
| 4 | $0.93 | 1,134 | $1K | 1.5% |
| 5 | $0.93 | 7,009 | $7K | 9.0% |
| 6 | $0.92 | 3,792 |
| $3K |
| 4.8% |
| 7 | $0.92 | 23,443 | $22K | 29.8% |
| 8 | $0.92 | 27,465 | $25K | 35.0% |
| Total | $0.93 avg | 77,843 | $72K | 100% |
| Filing → |
| IMPL | BUY | 2021-04-29 | $8.6M | — | Filing → |
| ALGS | BUY | 2020-10-20 | $8.3M | — | Filing → |
| CRNX | SELL | 2020-04-17 | $10.1M | — | Filing → |